This device is not available for sale in the US
AurisID
IMMY's Real-Time PCR test for the detection of clinically relevant Candida auris allows for more accurate diagnosis and faster time to proper treatment of this resistant species of Candida.
Over the past decade, Candida auris has emerged as a worldwide public health threat. Since its first isolation in 2009 in Japan, C. auris infections have been reported in over 30 countries. Pairing the increasing number of infections and the increase in resistance to common treatment methods, this fungus is a cause of concern.
Specimen Types & Registrations
- CE: Serum, Plasma, Surveillance Swab (axilla/groin, nasopharyngeal)
Product Reference
- OLM2010
Targets
- Candida auris
- Internal Extraction Control (IEC)
Performance Characteristics
- Sensitive to <10 Candida auris genome copies
- Proven efficacy in clinical decision making for infection control and patient management
Detect Early. Treat Fast. Save Lives.
Features & Benefits
Results Within 45 Minutes
Culture-Independent
